Brief: Hamlet Pharma Q3 Pretax Loss Widens To SEK 5.3 Million
21/05/2018 13:57
May 21 (Reuters) - HAMLET PHARMA AB HAMLET.TE :
* Q3 PRETAX LOSS SEK 5.3 MILLION VERSUS LOSS SEK 3.0 MILLION
YEAR
AGO
Source text for Eikon: ID:nNDL4C6F42
Further company coverage: HAMLET.TE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 587720920;))
Recent news on Hamlet BioPharma AB
See all newsBrief: Hamlet Biopharma Announces Completion Of Alpha1h Phase Ii Study In Non-Muscle Invasive Bladder Cancer
Brief: Hamlet Biopharma Holds Successful In Person Meeting With US FDA
Brief: Hamlet Pharma Q2 Loss Before Tax Narrows To SEK 2.8 Mln
Brief: Hamlet Pharma Gets Patent In Europe
Brief: Hamlet Pharma Gets Patent Granted In Europe